At a glance
ClinicalIndex Comparison RecordPhase 3Terminated· 18 enrolled
Drug / intervention
Celecoxib +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Celecoxib Polyp Prevention Trial in Participants With Resected Stage I Colon Cancer
In Brief
A Phase 3 clinical trial evaluating Celecoxib and placebo for Colorectal Cancer. Terminated early, enrolled 18 participants across 1 site.
Signals
Trial was terminated early
Detailed Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known whether celecoxib is effective in preventing polyps in patients with colon cancer. PURPOSE: Randomized phase III trial to study the effectiveness of celecoxib in preventing the development of polyps in patients who have undergone surgery for stage I colon cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 3TerminatedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2004
First PostedJul 2004
Primary CompletionApr 2006
TodayJul 2026
First PostedJul 12, 2004
Enrollment StartJul 1, 2004
Primary CompletionApr 1, 2006
TodayJul 1, 2026
Enrollment to primary: 1.8 yearsPosted 22.0 years ago
Interventions
Celecoxibdrug
placeboother